Journal entry, "Hyperbaric oxygen therapy (HBOT) is involved with remission costs [a time period in the course of which signs and symptoms of a condition are reduced or vanish] of 81% to 85% at two to a few many years in clients with Persistent refractory osteomyelitis." Carbonfree Licensed by ClimeCo waiting for link from Social Bookmarking